VCM
LUNG icon

Versant Capital Management’s Pulmonx LUNG Stock Holding History

Versant Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-333
Closed -$539 – 2702
2025
Q3 		$539 Buy
333
+185
+125% +$387 ﹤0.01% 2563
2025
Q2 		$383 Sell
148
-610
-80% -$2.41K ﹤0.01% 2566
2025
Q1 		$5.1K Buy
758
+175
+30% +$1.24K ﹤0.01% 2020
2024
Q4 		$3.96K Buy
+583
New +$3.84K ﹤0.01% 1869

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Versant Capital Management's LUNG Position: Q4 2025 in Review

Versant Capital Management sold out of Pulmonx (LUNG) in Q4 2025, closing a stake of 333 shares — an estimated $539 sold.

Versant Capital Management first reported a position in LUNG in Q4 2024 and held it in 4 quarters. The position peaked at $5.1K in Q1 2025. 112 funds tracked by Wall St. Rank hold LUNG as of Q4 2025.

  • Versant Capital Management reported no remaining Pulmonx position as of Q4 2025 after selling out during the quarter.
  • Versant Capital Management sold 333 Pulmonx shares in Q4 2025, an estimated $539.
  • Versant Capital Management first reported a position in Pulmonx in Q4 2024 and held it in 4 quarters.
  • Versant Capital Management's Pulmonx position peaked at $5.1K in Q1 2025.
  • 112 funds tracked by Wall St. Rank held Pulmonx as of Q4 2025.

Based on Versant Capital Management's 13F filing for Q4 2025, filed 8 Jan 2026.